Acute Ischemic Stroke (AIS) Market, by Therapeutics (Tissue Plasminogen Activator, Anticoagulant, Antiplatelet, and Antihypertensive), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), and by Region (North America, Eu

Acute Ischemic Stroke (AIS) Market, by Therapeutics (Tissue Plasminogen Activator, Anticoagulant, Antiplatelet, and Antihypertensive), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Acute ischemic stroke (AIS) is defined as the sudden loss of blood flow to an area of the brain with the consequent loss of neurological function. It is caused due to thrombotic or embolic occlusion of a cerebral artery and is more common than hemorrhagic stroke. Symptoms depend on the severity of the stroke and its location in the brain. Few people have no symptoms while Online Pharmacies only have one of the numerous symptoms. However, most people experience a combination of symptoms such as paralysis on one side of the body, changes in alertness, and changes in hearing or taste, difficulty in swallowing, dizziness or loss of balance, visual disturbances, and others.
Market Dynamics
Tobacco smoking is one of the major cause of cardiovascular disease, such as coronary heart disease, high blood pressure, heart attack, stroke, and Online Pharmacies. When a person smokes a cigarette, the blood that is distributed to the rest of the body becomes contaminated with chemicals in the smoke. These chemicals can damage the heart and blood vessels, which can lead to cardiovascular disease (CVD), the leading cause of death in the U.S. For instance, key facts provided by World Health Organization (WHO) in 2021, tobacco kills more than eight million people each year, globally. More than seven million of these deaths are due to direct tobacco use, while about 1.2 million are due to non-smokers exposed to secondhand smoke (combination of smoke from the burning end of a cigarette and the smoke breathed out by smokers). More than 80% of the world's 1.3 billion tobacco users live in low- and middle-income countries such as Bangladesh, India, Afghanistan, and Online Pharmacies.
Key features of the study:
This report provides in-depth analysis of the global acute ischemic stroke (AIS) market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global acute ischemic stroke (AIS) market based on the following parameters – company highlights, types portfolio, key highlights, financial performance, and market strategies
Key companies covered as a part of this study include F. Hoffmann-La Roche AG, Boehringer Ingelheim, Bayer AG, Pfizer Inc., Biogen, Daiichi Sankyo, Bristol-Myers Squibb, Johnson & Johnson, AstraZeneca, SanBio and Athersys Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global acute ischemic stroke (AIS) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global acute ischemic stroke (AIS) market
Detailed Segmentation:
Global Acute Ischemic Stroke (AIS) Market, By Therapeutics:
Tissue Plasminogen Activator
Anticoagulant
Antiplatelet
Antihypertensive
Global Acute Ischemic Stroke (AIS) Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Acute Ischemic Stroke (AIS) Market, By Region:
North America
By Therapeutics
Tissue Plasminogen Activator
Anticoagulant
Antiplatelet
Antihypertensive
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
U.S.
Canada
Latin America
By Therapeutics
Tissue Plasminogen Activator
Anticoagulant
Antiplatelet
Antihypertensive
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Therapeutics
Tissue Plasminogen Activator
Anticoagulant
Antiplatelet
Antihypertensive
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Therapeutics
Tissue Plasminogen Activator
Anticoagulant
Antiplatelet
Antihypertensive
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Therapeutics
Tissue Plasminogen Activator
Anticoagulant
Antiplatelet
Antihypertensive
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
GCC
Israel
Rest of Middle East
Africa
By Therapeutics
Tissue Plasminogen Activator
Anticoagulant
Antiplatelet
Antihypertensive
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region/Country
South Africa
Central Africa
North Africa
Company Profiles
F. Hoffmann-La Roche AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Boehringer Ingelheim
Bayer AG
Pfizer Inc.
Biogen
Daiichi Sankyo
Bristol-Myers Squibb
Johnson & Johnson
AstraZeneca
SanBio
Athersys Inc.

“*” marked represents similar segmentation in other categories in the respective section.